Essential (primary) Hypertension
Conditions
Interventions
This is a randomized controlled clinical trial with two arms, including 30 physically active university students, randomly allocated to an intervention group (n = 15) and a control group (n = 15). Ran
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Adults aged between 18 and 30 years; both sexes; physically active, classified as active according to the short version of the International Physical Activity Questionnaire (IPAQ); absence of cardiovascular diseases; absence of metabolic diseases; absence of musculoskeletal and/or osteoarticular conditions that may limit the performance of the proposed exercises; voluntary agreement to participate in the study through written informed consent.
Exclusion criteria
Exclusion criteria: Participants who do not complete all pre- and post-intervention assessments; attendance lower than 75% of the scheduled training sessions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Aerobic endurance assessed by the time to complete the 804.67-meter walk test from the American Alliance for Health, Physical Education, Recreation and Dance functional fitness battery before and after six weeks of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: Upper limb muscular strength assessed by the 30-second elbow flexion test from the American Alliance for Health, Physical Education, Recreation and Dance functional fitness battery before and after six weeks of intervention.;Expected outcome 3: Lower limb power assessed by a standardized functional test from the American Alliance for Health, Physical Education, Recreation and Dance functional fitness battery before and after six weeks of intervention.;Expected outcome 4: Agility and dynamic balance assessed by the agility test from the American Alliance for Health, Physical Education, Recreation and Dance functional fitness battery before and after six weeks of intervention.;Expected outcome 5: Resting systolic blood pressure and resting diastolic blood pressure measured using a validated automatic upper-arm blood pressure monitor before and after six weeks of intervention.;Expected outcome 6: Resting heart rate measured using a validated automatic upper-arm blood pressure monitor before and after six weeks of intervention. | — |
Countries
Brazil
Contacts
Public ContactAlessandra Medeiros
Universidade Federal de São Paulo
Outcome results
None listed